|
SDHB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.73070446862766E-11 |
| Normal-vs-Stage3 |
3.88844512144715E-12 |
| Normal-vs-Stage4 |
1.2103000002206E-07 |
| Stage1-vs-Stage2 |
2.042400E-01 |
| Stage1-vs-Stage3 |
3.350800E-01 |
| Stage1-vs-Stage4 |
6.815400E-01 |
| Stage2-vs-Stage3 |
7.108600E-01 |
| Stage2-vs-Stage4 |
6.207800E-01 |
| Stage3-vs-Stage4 |
8.399800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.27276008913213E-14 |
| Normal-vs-Asian |
3.017000E-04 |
| Caucasian-vs-AfricanAmerican |
6.753600E-01 |
| Caucasian-vs-Asian |
6.393800E-01 |
| AfricanAmerican-vs-Asian |
7.890600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62592161956354E-12 |
| Male-vs-Female |
7.347600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66267000167863E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
5.55111512312578E-16 |
| Normal-vs-Extreme_Obese |
1.796390E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.193200E-01 |
| Normal_Weight-vs-Obese |
7.170400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.188600E-01 |
| Extreme_Weight-vs-Obese |
5.765400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.237600E-01 |
| Obese-vs-Extreme_Obese |
2.608800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.65840005353857E-09 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.19019999703596E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.364400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.993800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.094000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.711190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.793600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.334600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.93950427834966E-11 |
| Normal-VS-KIRP CIMP |
2.77830003447832E-09 |
| Normal-VS-Unclassified PRCC |
1.64057656348859E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.628120E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.367190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.816200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.710100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.162300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.554000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38142838782096E-13 |
| Normal-vs-N1 |
4.6207482284899E-13 |
| Normal-vs-N2 |
8.03199999954707E-07 |
| N0-vs-N1 |
8.726000E-02 |
| N0-vs-N2 |
1.284960E-01 |
| N1-vs-N2 |
4.692400E-01 |
|
|
